Your browser is no longer supported. Please, upgrade your browser.
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E18.88 EPS (ttm)2.19 Insider Own0.04% Shs Outstand5.60B Perf Week-1.76%
Market Cap232.67B Forward P/E11.04 EPS next Y3.74 Insider Trans-0.32% Shs Float5.59B Perf Month-5.86%
Income12.40B PEG1.52 EPS next Q1.09 Inst Own67.50% Short Float0.93% Perf Quarter0.66%
Sales55.52B P/S4.19 EPS this Y-33.10% Inst Trans0.08% Short Ratio1.59 Perf Half Y5.87%
Book/sh12.51 P/B3.30 EPS next Y-9.08% ROA8.00% Target Price46.23 Perf Year14.89%
Cash/sh3.85 P/C10.72 EPS next 5Y12.42% ROE19.80% 52W Range32.79 - 51.86 Perf YTD12.25%
Dividend1.56 P/FCF18.51 EPS past 5Y2.20% ROI7.60% 52W High-18.84% Beta0.72
Dividend %3.78% Quick Ratio1.10 Sales past 5Y-3.00% Gross Margin74.70% 52W Low28.36% ATR0.81
Employees78500 Current Ratio1.40 Sales Q/Q92.40% Oper. Margin24.30% RSI (14)40.81 Volatility1.59% 1.77%
OptionableYes Debt/Eq0.56 EPS Q/Q111.20% Profit Margin23.80% Rel Volume0.52 Prev Close41.32
ShortableYes LT Debt/Eq0.50 EarningsNov 02 BMO Payout65.10% Avg Volume32.81M Price42.09
Recom2.60 SMA20-1.41% SMA50-6.88% SMA2005.81% Volume17,062,916 Change1.86%
Jul-27-21Resumed Truist Buy $43
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Oct-19-21 03:35PM  
01:00PM  
11:15AM  
10:30AM  
10:30AM  
08:58AM  
07:00AM  
06:58AM  
06:34AM  
05:52AM  
02:05AM  
Oct-18-21 07:30PM  
07:29PM  
06:43PM  
05:45PM  
05:10PM  
01:17PM  
01:05PM  
11:40AM  
11:19AM  
11:03AM  
10:31AM  
10:29AM  
06:00AM  
05:16AM  
Oct-17-21 03:38PM  
02:31PM  
Oct-16-21 03:56PM  
09:01AM  
06:04AM  
Oct-15-21 05:47PM  
05:41PM  
04:30PM  
04:28PM  
04:24PM  
03:49PM  
03:02PM  
02:54PM  
02:51PM  
02:42PM  
02:14PM  
02:13PM  
02:12PM  
01:54PM  
01:42PM  
11:51AM  
10:15AM  
10:01AM  
09:01AM  
08:18AM  
07:50AM  
06:55AM  
06:45AM  
06:05AM  
04:00AM  
02:40AM  
Oct-14-21 07:20PM  
05:45PM  
05:00PM  
04:34PM  
04:23PM  
04:20PM  
04:10PM  
03:56PM  
03:52PM  
03:41PM  
02:37PM  
12:48PM  
12:16PM  
11:30AM  
10:05AM  
09:14AM  
07:01AM  
06:30AM  
06:20AM  
06:00AM  
06:00AM  
Oct-13-21 08:12PM  
07:15PM  
04:57PM  
04:41PM  
04:24PM  
04:09PM  
04:08PM  
02:32PM  
01:13PM  
11:38AM  
09:11AM  
08:30AM  
07:19AM  
06:30AM  
06:20AM  
05:30AM  
Oct-12-21 09:39PM  
07:46PM  
05:31PM  
05:00PM  
04:15PM  
02:30PM  
02:24PM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerAug 13Sale48.301,66180,2269,769Aug 16 08:12 PM
DAMICO JENNIFER B.SVP & ControllerJul 30Sale42.862,500107,15011,430Aug 02 07:02 PM
DAMICO JENNIFER B.SVP & ControllerMay 05Sale40.822,500102,05013,748May 07 04:10 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM